UnitedHealth Group Incorporated

UnitedHealth Group Incorporated

UNHNYSE / NASDAQHealthcareLarge cap

$339.85+$9.37 (+2.8%)

Last close · Data as of Nov 20, 2026

Market cap
$360.1B
P/E
29.9x
EV / EBITDA
18.0x
Revenue
$447.6B
Net margin
2.7%
ROCE
9.7%

+9.1% over the last year

UnitedHealth Group Incorporated price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-18.9%
3M
-11.7%
6M
-11.3%
1Y
+9.1%
5Y
-22.8%

52-week range

Day change +$9.37 (+2.8%) from $330 to $340 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in UNH, bought on each weekday since 2021.

News & filings

What UnitedHealth Group Incorporated filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernNet margin of 2.7% against a peer median of 24.5%.

Strengths (1)

  • Free cash flow was 1.33 times net profit in fiscal 2025.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.

Read moreShow less

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Sector
Healthcare
Shares outstanding
905.8M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$360.1B
P/E
29.9x
P/B
3.8x
EV / EBITDA
18.0x
EV / Sales
0.9x
P/S
0.8x
52-week high
$436.35
52-week low
$259.02

Profitability

Operating margin
4.2%
Net margin
2.7%
EBITDA margin
5.2%
ROE
12.8%
ROCE
9.7%
ROA
3.9%
Asset turnover
1.45

Growth

Revenue
$447.6B
Revenue growth, 1Y
11.8%
Revenue CAGR, 3Y
11.4%
Net profit growth, 1Y
-16.3%
Free cash flow
$16.1B

Solvency

Current ratio
0.79
Debt / Equity
0.83
Debt / Assets
0.25
CFO / Net profit
1.63
Cash / Market cap
6.8%

Where the revenue went

Of every $100 of FY2025 revenue, $3 was left as net income.

UnitedHealth Group Incorporated income statement flow, FY2025
UnitedHealth Group Incorporated income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$364.6B
RevenueGross profit$82.9B
Gross profitOperating expenses$64.0B
Gross profitOperating income$19.0B
Operating incomePretax income$14.7B
Operating incomeInterest and other expense$4.3B
Pretax incomeTax and other$2.6B
Pretax incomeNet income$12.1B

Revenue and net profit

Revenue grew 11.8% in FY2025; net profit is the dashed line.

UnitedHealth Group Incorporated revenue and net profit by fiscal year
UnitedHealth Group Incorporated revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$324.2B$20.1B
FY2023$371.6B$22.4B
FY2024$400.3B$14.4B
FY2025$447.6B$12.1B

Cash flows

FY2025: $19.7B from operations, $16.1B free after investment (dashed).

UnitedHealth Group Incorporated operating and free cash flow by fiscal year
UnitedHealth Group Incorporated operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$26.2B$23.4B
FY2023$29.1B$25.7B
FY2024$24.2B$20.7B
FY2025$19.7B$16.1B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$447.6B+11.8%1Y
EBITDA
$23.1B-17.9%1Y
Net profit
$12.1B-16.3%1Y
Cash from operations
$19.7B-18.6%1Y
Free cash flow
$16.1B-22.4%1Y
Revenue CAGR, 3Y
11.4%
Net profit CAGR, 3Y
-15.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$447.6B$23.1B$12.1B$16.1B12.8%+11.8%-16.3%

Monthly returns

Month-by-month returns of UNH across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$309.6B
Liabilities$207.9B
Equity$101.7B
Paid-in capital$559.0M
Retained earnings$95.6B
Minority interest$7.6B

Market cap against peers

8 peers: same sector, nearest by size.

  1. UnitedHealth Group Incorporated (this company)$360.1B
  2. Amgen Inc.$186.5B

Peers map

Healthcare companies placed by value, growth and quality; UNH highlighted.

P/E against peers

UNH trades at 29.9x earnings against a peer median of 24.2x (a 23% premium).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
UnitedHealth Group IncorporatedUNHthis companyP/E ↑ premium$360.1B29.9x3.8x12.8%18.0x
Johnson & JohnsonJNJ$549.3B20.5x6.7x32.9%14.1x
AbbVie Inc.ABBV$397.4B94.9x—-128.0%26.1x
Merck & Co., Inc.MRK$297.0B16.3x5.6x34.7%11.7x
Amgen Inc.AMGN$186.5B24.2x21.5x89.1%13.7x
Thermo Fisher Scientific Inc.TMO$179.1B26.7x3.4x12.6%18.1x
Gilead Sciences, Inc.GILD$160.4B18.8x7.1x37.5%12.9x
Abbott LaboratoriesABT$158.1B24.2x3.0x12.5%13.5x
Intuitive Surgical, Inc.ISRG$148.3B51.9x8.3x16.0%39.3x
Peer median—24.2x6.7x24.4%13.9x

Year-to-date ROI

UNH since 1 January, against earlier years.

Historical volatility

UNH's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

UnitedHealth Group Incorporated operating margin by fiscal year
UnitedHealth Group Incorporated operating margin by fiscal year
DateOperating margin
FY20228.8%
FY20238.7%
FY20248.1%
FY20254.2%
LineFY2025
Cost of revenueCost Of Revenue$364.6B
Gross profitGross Profit$82.9B
Operating expensesOperating Expense$64.0B
Other operating expensesOther Operating Expenses$59.6B
Depreciation and amortisationDepreciation And Amortization In Income Statement$4.4B
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$4.4B
Total expensesTotal Expenses$428.6B
Pretax incomePretax Income$14.7B

Learn while you research

Academy chapters picked for UnitedHealth Group Incorporated and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →